Modified DHAP-salvage therapy for refractory and/or relapsed classic Hodgkin's (CHL) and non-Hodgkin's lymphomas (NHL)

Authors
Category Primary study
Conference64th Annual Scientific Meeting of the British Society for Haematology
Year 2024
This article has no abstract
Epistemonikos ID: a7cd5f1207c836cd7ad971bef129f45769d010ea
First added on: Jan 07, 2026